US 9896511
Antibodies that bind to TL1A and methods of treating inflammatory or autoimmune disease comprising administering such antibodies
granted A61KA61K2039/505
Quick answer
US patent 9896511 (Antibodies that bind to TL1A and methods of treating inflammatory or autoimmune disease comprising administering such antibodies) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary, Dept. of Health and Human Services
- Grant date
- Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/505